Clinical Trial

Pre-trial of Clinical Trial of Traditional Chinese Medicine Treatment for Elderly Patients With Coronary Heart Disease Who Are Still Symptomatic After Optimal Medical Treatment

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
To explore the effectiveness of compound Danshen Dripping Pill and Qishen Yiqi Dripping Pill in the elderly population with coronary heart disease and the safety of multiple medications
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-19.
Status change: Not Yet Recruiting → Recruiting 2025-09-24
Trial Details
NCT Number NCT07041359
Lead Sponsor China National Center for Cardiovascular Diseases
Conditions Coronary Arterial Disease (CAD)
Enrollment 120 participants
Start Date 2025-08-18
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-29